EZH2 and myelodysplastic syndrome: On the other hand, EZH2, which catalyses H3K27me3, was down-regulated in MDS CD34+ cells according to MDS CD34+ cell microarray and was suppressed in Bmi1-transfected K562 cells verified by western blotting.